CABAZITAXEL for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 20 adverse event reports in the FDA FAERS database where CABAZITAXEL was used for Neoplasm malignant.
Most Reported Side Effects for CABAZITAXEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 197 | 7.7% | 66 | 119 |
| Malignant neoplasm progression | 172 | 6.7% | 18 | 23 |
| Fatigue | 160 | 6.3% | 17 | 67 |
| Prostatic specific antigen increased | 148 | 5.8% | 11 | 23 |
| Pyrexia | 145 | 5.7% | 48 | 94 |
| Disease progression | 143 | 5.6% | 46 | 27 |
| Diarrhoea | 142 | 5.6% | 34 | 70 |
| Anaemia | 127 | 5.0% | 30 | 58 |
| Neutropenia | 126 | 4.9% | 27 | 50 |
| Drug ineffective | 125 | 4.9% | 25 | 20 |
| Dyspnoea | 113 | 4.4% | 42 | 49 |
| Haematuria | 108 | 4.2% | 11 | 49 |
| Asthenia | 101 | 4.0% | 18 | 59 |
| Decreased appetite | 89 | 3.5% | 18 | 52 |
| Nausea | 81 | 3.2% | 13 | 41 |
Other Indications for CABAZITAXEL
Prostate cancer (764)
Hormone-refractory prostate cancer (524)
Prostate cancer metastatic (451)
Product used for unknown indication (237)
Metastases to bone (28)
Adenocarcinoma (27)
Bladder cancer (23)
Chemotherapy (17)
Prostate cancer stage iv (15)
Bone cancer (11)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)